HRTX

Heron Therapeutics INC

-$79.1M

Net Activity

Institutions Holding

168

Popularity Rank

#3326

Avg Weight

0.08%

Total Value

$128.2M

Ownership Trend

168 institutions currently hold HRTX, with 79 net buyers and 73 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

73

Net Buying Institutions

79

Key Holders

View all 168 holding institutions

Quarterly Activity

Recent Activity

+$45.8M

Total Buy Value

$67.9M

Total Sell Value

New buy25
Trim44
Add54
Sold out29

79

Net Buyers

73

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding HERON THERAPEUTICS INC (HRTX)?
Major stakeholders currently include Rubric Capital Management LP ($24.0M), Clearline Capital LP ($9.8M), BlackRock, Inc. ($8.1M). Based on the latest 13F filings, there are a total of 168 tracked investment funds and institutions maintaining positions in HRTX.
What is the overall institutional sentiment toward HRTX recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $79.1M, driven by 79 managers accumulating shares while 73 reduced their exposure.
Which institutions have been selling or reducing their HRTX positions?
In the latest period, 44 funds trimmed their holdings, and 29 managers completely exited their positions. The aggregate reported sell value was $67.9M.
Are there any notable investors adding HRTX to their portfolios?
Yes, buying activity remains notable. 25 institutions opened new positions in {ticker}, and 54 existing holders added to their shares. The total reported buy value for the quarter amounted to $45.8M.

Related Stocks